## 6 Regulatory, Ethical and Privacy Considerations
Employees should be fully informed about the purpose, risks and benefits of POCT-based screening initiatives and must retain the right to refuse participation without fear of reprisal. Data privacy and cybersecurity represent critical operational domains. Organizations must implement robust technical safeguards, including end-to-end encryption, secure authentication protocols and regular vulnerability assessments, to protect sensitive health \begin{table}
\begin{tabular}{p{142.3 pt} p{142.3 pt}} \hline \hline
**Framework** & **Description** \\ \hline Health Insurance Portability and Accountability Act (HIPAA) & In the United States, HIPAA establishes standards for the protection of sensitive health information. Employers offering workplace health services must ensure that POCT results and digital passport data are securely managed and not disclosed without employee consent. \\ \hline General Data Protection Regulation (GDPR) & In Europe, the GDPR classifies health data as “special category” personal data, requiring explicit consent for its processing and strict compliance with data minimization and purpose limitation principles. \\ \hline Occupational Safety and Health Administration (OSHA) & Employers must balance the benefits of health surveillance with OSHA regulations, ensuring that health screening programs are voluntary unless mandated by specific workplace hazards. \\ \hline Food and Drug Administration (FDA) Oversight & In the US, POCT devices must often be approved under the Clinical Laboratory Improvement Amendments (CLIA) as “waived” devices for simplicity and low risk or to meet Emergency Use Authorization (EUA) standards during public health emergencies. \\ \hline International Standards & Global frameworks such as ISO 15189 (quality and competence for medical laboratories) [77] and WHO guidelines on decentralized diagnostics provide guidance on POCT quality management. \\ \hline \hline \end{tabular}
\end{table} 
Table 4: Regulatory frameworks related to digital health monitoring across different countries and regions. information from unauthorized access or breaches [72; 79]. Anonymization and aggregation techniques should be employed whenever feasible to protect individual identities in workforce health analytics. Transparent governance structures, third-party audits and clear communication strategies can further enhance accountability and foster a culture of trust essential for the long-term success of workplace health programs utilizing POCT and digital health passports. The arrival of POCT and rapid testing for cancer and other chronic diseases in the workplace is likely to evoke strong and polarized opinions and views. Broadly, these may comprise moral, ethical and social concerns [80] and considerations both for and against their application in a workplace context throughout the system identification and requirements elicitation activities. Such views could likewise extend to opinions or concerns about testing and screening for more common and, in the main treatable, diseases such as high blood pressure (hypertension), high cholesterol (hyperlipidaemia), diabetes and obesity (collectively known as 'lifestyle' diseases). An examination of the relevant ethical questions, issues and implications surrounding a potential workplace-based system should be undertaken [81]. Proposed workplace-testing regimes and initiatives must have due regard to a number of general ethical principles. The nature and manner of testing within the workplace must be acceptable both to individuals (employees) tested and to employers and other stakeholders (insurers, etc.) affected. Testing should only be introduced if a clear and important benefit can be demonstrated. Suggested social, community or group benefits of relative unquantifiable worth should be disregarded. Testing results must be treated in a way that individuals' preferences in privacy and confidentiality are respected. Testing procedures should reflect fairness and impartiality.